Christopher R. Loose Frequency Therapeutics, Inc. (FREQ) insider trading activity

FREQ Quotes by TradingView

Christopher R. Loose is Chief Scientific Officer of Frequency Therapeutics, Inc.. Currently has a direct ownership of 183,650 shares of FREQ, which is worth approximately $0. The most recent transaction as insider was on Feb 17, 2022, when has been sold 900 shares (Common Stock) at a price of $4.19 per share, resulting in proceeds of $3,771. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 184K
0% 3M change
2.16% 12M change
Total Value Held $0

Christopher R. Loose Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 17 2022
SELL
Open market or private sale
$3,771 $4.19 p/Share
900 Reduced 2.38%
36,870 Common Stock
Feb 16 2022
SELL
Open market or private sale
$3,770 $4.43 p/Share
851 Reduced 2.2%
37,770 Common Stock
Feb 15 2022
SELL
Open market or private sale
$3,737 $4.33 p/Share
863 Reduced 2.19%
38,621 Common Stock
Feb 14 2022
BUY
Exercise of conversion of derivative security
-
15,000 Added 27.53%
39,484 Common Stock
Feb 03 2021
SELL
Open market or private sale
$94,380 $47.19 p/Share
2,000 Reduced 8.41%
21,782 Common Stock
Feb 02 2021
SELL
Open market or private sale
$360,160 $45.02 p/Share
8,000 Reduced 25.17%
23,782 Common Stock
Jan 27 2021
SELL
Open market or private sale
$340,000 $42.5 p/Share
8,000 Reduced 20.11%
31,782 Common Stock
Dec 17 2020
SELL
Open market or private sale
$330,000 $41.25 p/Share
8,000 Reduced 16.74%
39,782 Common Stock
Dec 16 2020
SELL
Open market or private sale
$311,440 $38.93 p/Share
8,000 Reduced 14.34%
47,782 Common Stock
Dec 15 2020
SELL
Open market or private sale
$298,240 $37.28 p/Share
8,000 Reduced 12.54%
55,782 Common Stock
Dec 14 2020
SELL
Open market or private sale
$280,000 $35.0 p/Share
8,000 Reduced 11.14%
63,782 Common Stock
Nov 09 2020
SELL
Open market or private sale
$192,000 $24.0 p/Share
8,000 Reduced 10.03%
71,782 Common Stock
Nov 05 2020
SELL
Open market or private sale
$184,000 $23.0 p/Share
8,000 Reduced 9.11%
79,782 Common Stock
Oct 13 2020
SELL
Open market or private sale
$176,000 $22.0 p/Share
8,000 Reduced 8.35%
87,782 Common Stock
Oct 08 2020
SELL
Open market or private sale
$168,960 $21.12 p/Share
8,000 Reduced 7.71%
95,782 Common Stock
Oct 07 2020
SELL
Open market or private sale
$160,000 $20.0 p/Share
8,000 Reduced 7.16%
103,782 Common Stock
Oct 06 2020
SELL
Open market or private sale
$155,680 $19.46 p/Share
8,000 Reduced 6.68%
111,782 Common Stock
Oct 05 2020
SELL
Open market or private sale
$146,800 $18.35 p/Share
8,000 Reduced 6.26%
119,782 Common Stock
Oct 02 2020
SELL
Open market or private sale
$151,360 $18.92 p/Share
8,000 Reduced 5.89%
127,782 Common Stock
Oct 01 2020
SELL
Open market or private sale
$150,720 $18.84 p/Share
8,000 Reduced 5.56%
135,782 Common Stock
CRL

Christopher R. Loose

Chief Scientific Officer
Lexington, MA

Track Institutional and Insider Activities on FREQ

Follow Frequency Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FREQ shares.

Notify only if

Insider Trading

Get notified when an Frequency Therapeutics, Inc. insider buys or sells FREQ shares.

Notify only if

News

Receive news related to Frequency Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FREQ